HDAC9 and neoplasm: HDAC inhibitors have been shown to induce tumor cell death, promote differentiation, suppress cell proliferation and cell cycle progression in vitro and inhibit angiogenesis, reduce tumor growth, and enhance immune responses of the host in vivo [8].